r/Asensus • • Jul 08 '21

News Asensus Surgical (ASXC) Stock Sees Sell-Off At Higher Level: A Good Buy Now?

Thumbnail
smallcapexclusive.com
2 Upvotes

r/Asensus • • Mar 11 '21

Discussion In a nutshell

10 Upvotes

Decent 2020 results. Poor outlook: it can justify a price about $3 or $4, not higher.

I’ll hold it for one or two quarters more, to see if there will be an acceleration of revenues.

They have to start to deliver. It’s now or never


r/Asensus • • May 01 '21

News All pump dump posts will be delated and profiles muted. Dont spread fomo and fud pls :)

26 Upvotes

r/Asensus • • Feb 25 '21

Discussion Bad, but not so bad

5 Upvotes

Market was really awful. After +524% YTD, it could’ve been much worse


r/Asensus • • Feb 26 '21

Discussion Why TRXC is inactive on Wealthsimple??!!!

6 Upvotes

r/Asensus • • Apr 19 '21

Discussion They removed the ability to comment on their Linkedin posts 🤨

Thumbnail
gallery
7 Upvotes

r/Asensus • • Mar 16 '21

News Asensus Surgical Inc. - Advertising

Thumbnail
youtu.be
13 Upvotes

r/Asensus • • May 26 '21

News Yesterday First Trust also announced they have bought more than 1%

Post image
14 Upvotes

r/Asensus • • Apr 29 '21

Gain Institutional investors as of 4/28/2021

Post image
14 Upvotes

r/Asensus • • Apr 08 '21

News Still searching for news

15 Upvotes



Home»Devices» Analysis

Robotic laparoscopy: Is it the future of minimally-invasive surgical procedures?

DEVICESMEDICAL AND SURGICAL

By Peter Littlejohns  03 Apr 2021

The field of robotic laparoscopy has a bright future, with several competitors lining up to challenge the incumbent market leader Intuitive Surgical  The market for robotic laparoscopy devices is expected to surge with increasing competition (Credit: Shutterstock/MONOPOLY919) Surgical robots have been growing slowly in prevalence since the late 1980s, when the first operative device was introduced. One trend to emerge fairly soon after was the use of robotic arms in laparoscopic procedures, a method with now heavily-proven patient benefits, but a technology that carries a high cost for hospitals.  Peter Littlejohns finds out from Asensus Surgical CEO Anthony Fernando why the benefits of robotic laparoscopy procedures have yet to be reflected in their uptake, and what an injection of competition could mean for the future.    Ten years ago, the chances are a laparoscopic procedure, known colloquially as keyhole surgery, would have been performed using a long, slender implement with grasping or cutting tools on the end. These tools would be operated by members of the surgical team, sometimes using multiple laparoscopes at once, to cut, hold and stitch as required. Now, depending on the procedure, it’s not unlikely that certain laparoscopic surgeries are performed by a robot. But far from the futuristic scenario hinted at in the many variations of the phrase The Robot Doctor Will See You Now seen in headlines – the reality is far less automated. Instead, the up-to-six robotic arms of these modern laparoscopic surgery machines are an extension of a surgeon’s physical capabilities, giving them the extra degrees of freedom required to access parts of the body that would be limited by a regular laparoscope or by the human arm. Although the journey of using robots for physically invasive surgeries began in 1985, when a stereotactic brain biopsy was carried out by the Puma 560 from pioneering robotics firm Unimation – much of the credit for commercialising robotic assisted laparoscopy is given to da Vinci. Not the famous painter and inventor, but the first commercial laparoscopic robotic device. Launched by Sunnyvale, California-based Intuitive Surgical back in 1998, the first da Vinci was cleared for general surgery by the FDA in 2000. Since then, further iterations of the technology have been used to perform thousands of surgeries in the more than 5,000 hospitals with a da Vinci in residence. Intuitive isn’t the only player in town right now, but Anthony Fernando, CEO of competitor Asensus Surgical doesn’t shy away from crediting the firm for the paradigm shift it started in the field of robotic laparoscopy. “They [Intuitive] converted open surgery to minimally-invasive surgery and reduced the length of stay at the hospital. “This reduction in cost from the length of stay offset the incremental cost of the instruments. “But in the process of doing that, they created a new minimally-invasive technique that was unique to them. “It wasn’t laparoscopy, nor was it open surgery – it was something in between.” The value of using robotics in surgery can be determined by the type of operation for which it is used. Anthony Fernando, CEO of Asensus Surgical (Credit: Asensus Surgical) A recent article in Nature stated that in 2003, less than 1% of surgeons in the US performed a robotic-assisted radical prostatectomy (RARP) in preference to open or laparoscopic surgery – but by 2014 RARP accounted for 90% of radical prostatectomies across the country. Despite this, according to Fernando, around half of all surgeries are done using the laparoscopic approach, but less than 5% are carried out using robotics. He believes this relatively small percentage is largely due to cost, and like the other competitors to Intuitive, is banking on an increase in competition resulting in more market penetration in the field of robotic laparoscopy in the future.  

The cost and value of robotic laparoscopy

If a hospital wants to harness the power of da Vinci, they have to pay a flat cost around the $2m mark, dependant on which model they purchase, and more to cover disposable implements attached during surgery. Although competitors like Asensus with its Senhance offering, CMR Surgical with Versius and the incoming rival Medtronic with its Hugo bot are keeping their cards close to their chests publicly as far as price tags go, it’s this high cost they hope to compete on. “It’s not so much the cost of capital but the cost per use that’s a big hindrance,” says Fernando. “The argument [from hospitals] is that laparoscopy is super effective, there are many trained surgeons, and it’s really economical, so there’s no need for a laparoscopist to get a robot.” Where that argument breaks down, Fernando says, is when hospitals have to consider the physical and mental ramifications of conducting several laparoscopies in one day. “In the US, the majority of the good laparoscopic surgeons are over the age of 50, and out of that cohort, more than half have had some sort of back or shoulder surgery because of an injury caused by standing in very awkward positions for hours each day. “If you look at variability in surgeries, those performed in the morning hours of the day tend to have better outcomes than those performed in the afternoon, and this is primarily due to cognitive fatigue.” Mitigating these risks is where Fernando sees the value of robotic laparoscopy, and he says his company’s Senhance robot can do it at 70% of the per-procedure cost that da Vinci can.  

The future of robotic laparoscopy

Many analysts expect the competition from new players in the market to reduce the average cost paid by hospitals to acquire the capacity to perform robotic laparoscopy procedures – but in the future, that alone won’t determine who the dominant players are. Fernando asks: “When you think about robotic laparoscopy today, what have we done?” “We can hold an instrument and manipulate it in a very stable and precise manner, but that’s all, whether it’s CMR, us or Intuitive, we do the same thing. “The next phase is the cognitive side of things, which is what we’ve already launched the Intelligent Surgical Unit for.” Robotic laparoscopy systems are carried out by surgeons sat at a computer console, through which they can view the inside of a patient using a camera on the end of each robotic arm. Asensus Surgical’s Intelligent Surgical Unit is the name given to a piece of machine-learning technology in the software that runs its own consoles which records data from successful surgeries and uses it to give best-practice guidance to others. Asensus Surgical uses machine learning to guide its Senhance robotic system (Credit: Asensus Surgical) “We’re building a digital twin for the surgeon. We can learn from everywhere what good surgery looks like, and help deploy it anywhere,” Fernando adds. In practice, this will appear as physical cues for surgeons, and due to the nature of training a machine-learning system, it will apply more to routine, formulaic surgeries than those of a more complex nature that rely heavily on experience and skill. “For instance, when you do a gastric sleeve you’re focusing on stapling a certain portion of the stomach. “There’s a formulaic methodology that surgeons use to decide where to put the staple line, but if this rough calculation is not done right you have potential acid reflux as well as other side effects. “But we are now able to measure, in 3D space and in real time, the size of the stomach, and be very precise and avoid that.” One benefit of this approach is that this “navigation system”, as Fernando describes it, can account for individual patient differences and complications by pulling together a range of data from similar surgeries done on similar patients to take some of the mental stress of deciding next steps from the surgeon. In doing this, Asensus hopes to reduce the mental fatigue associated with current laparoscopies and prevent some of the risk associated with surgeries carried out after a laparoscopist has already performed several procedures in the same day. Fernando adds that this intelligent assistant could even supplant the long-awaited telesurgery – procedures carried out remotely, so a surgeon can sit at a console and control robotic arms located at great distances away. Telesurgeries have been performed already, but they aren’t considered to be a reliable option for most patients, especially when longer distances increases the risk of lag time between a surgeon’s input and the movement of a robotic arm – that is until 5G is pervasive enough to cut lag altogether. “5G will allow that, but the reason I say ‘will’ is that you actually need true 5G,” says Fernando. “There’s true 5G in London and in about two cities in the US, but that’s it. The distinction he draws is between the current mobile 5G in wide circulation and another more complex variation of the technology that provides much stronger connections over long distances – but even with that technology incoming in the near future, Fernando questions whether it will be necessary. He asks: “If we are successful in digitising surgery and leveraging machine learning algorithms and AI, do you actually need telepresence?”  

Will there ever be a truly automated robotic laparoscopy?

Once machine learning comes into play, it’s only a matter of time before we’re talking about how near in the future there will be full automation in robotic laparoscopy, with little to no human intervention. But when you’re talking about the risk of a life-altering mistake in the surgical theatre, it’s obvious that hospitals and regulators are going to be reluctant to completely hand over the keys to an AI. As it is, Fernando says Asensus took 12 years to build and bring Senhance to market with all of the required regulatory clearance. But despite this, he doesn’t rule out the prospect of more automation in laparoscopic surgery in the future – although he doubts that having the capability will mean that it is adopted. He says: “There will come a time that the capability will exist,” but he asks “will surgeons be willing to take advantage of that?” “A plane can take off and touch down by itself, but does it happen today? “Autopilot technology has existed for about 30 years now, but still there are two pilots in every aircraft that takes off.” When it comes to robotic laparoscopy however, Fernando believes the future ten years will yield a dramatic uptake in the technology. “It will be pretty dominant,” he concludes “I could see [penetration rates] being well north of 10% or 15%. “There’s no hospital or surgeon that we’ve spoken to that doesn’t agree that the future is robotics”


r/Asensus • • Nov 04 '21

Gain 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀

17 Upvotes

r/Asensus • • May 18 '21

News Hold Asensus Surgical Stock as Next-Gen Senhance System Gains Traction

Thumbnail
investorplace.com
21 Upvotes

r/Asensus • • Jun 01 '21

News A good quality DD from Seekingalpha

Post image
23 Upvotes

r/Asensus • • Mar 11 '21

News ASENSUS EPS BEATS BY $0.03

30 Upvotes

Asensus Surgical (NYSEMKT:ASXC):

Q4 Non-GAAP EPS of -$0.09 beats by $0.03;

GAAP EPS of -$0.13 misses by $0.01.

Revenue of $1.11M (+60.9% Y/Y) beats by $0.14M

Closed two equity financings, totaling approximately $111 million in gross proceeds in aggregate, extending cash runway into 2024.

Cash and cash equivalents and restricted cash of approximately $17.5 million as of December 31, 2020.


r/Asensus • • Mar 03 '21

News WE GET IT!

32 Upvotes

Street Insider: Asensus Surgical Announces FDA Clearance in General Surgery

https://www.streetinsider.com/Business+Wire/Asensus+Surgical+Announces+FDA+Clearance+in+General+Surgery/18070727.html

Page Excerpt:

Indications Expand to Include New Procedures in Large General Surgery Market RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: TRXC) , a medical device company that is digitizing the ...

Click here to view story in Bloomberg

Inviato da iPhone


r/Asensus • • Jul 07 '21

News Explorer Surgical will be partnering with Asensus Surgical, Dr. Vasili Karas, MD, MS, and Coring Group

8 Upvotes

r/Asensus • • Apr 05 '21

News Big buyer of July $5 call. Bullish

17 Upvotes

Asensus Surgical Inc Option Volume Jumps

By Bloomberg Automation

(Bloomberg) -- Trading in options of Asensus Surgical Inc. rose to four times the 20-day average for this time of day, according to data compiled by Bloomberg.

Click here to see the company's most active options.

Options trading at 10:10 a.m. New York time totaled 7,632 contracts vs average of 1,840 Calls reached 7,557 contracts on open interest of 165,162 Puts reached 75 contracts on open interest of 35,818 The most active contracts include:

July 16, 2021 $5 calls; 3,505 traded, 8,418 open interest July 16, 2021 $3 calls; 3,500 traded, 6,263 open interest April 16, 2021 $3.50 calls; 109 traded, 3,295 open interest Trading data:

Three-month at-the-money implied volatility increased to 130.3 from 123.8 at the previous close Asensus Surgical Inc shares fell 0.4 percent to $3.49 The three-month 90-110 skew is 4.9. A high skew value indicates more demand for downside protection versus demand for upside participation Click here for the company's Option Monitor and use the Exch field to see trading across exchanges.

Asensus Surgical Inc has no events on the Bloomberg Events Calendar in the next month.

Related ticker: ASXC US (Asensus Surgical Inc)

To contact Bloomberg News for this story: +1-212-617-2000 or [email protected]

This story was produced by Bloomberg Automation.

Topics Bloomberg Auto Intelligence (BAI) Real-Time Options Surges (RTOPTBAI) Real-Time Options Surges US (RTOPTUS)


r/Asensus • • May 11 '21

News Today 👿

Post image
13 Upvotes

r/Asensus • • Jul 24 '21

News 8-K Material Event Fri Jul 23 2021

Thumbnail
last10k.com
8 Upvotes

r/Asensus • • Nov 15 '21

News A new lease!

21 Upvotes

Asensus Surgical Announces Franklin Medical Center to Initiate the Installation of the Senhance Surgical System November 15, 2021 Franklin Medical Center to become 4th Senhance Hospital in Louisiana RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Nov. 15, 2021-- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided SurgeryTM, today announced the Franklin Medical Center in Winnsboro, Louisiana has entered into an agreement to lease and utilize a Senhance® Surgical System. “WeareexcitedtobringtheSenhancesystem'suniquecapabilitiestoyetanotherinnovativehospitalintheUnitedStates,”said AnthonyFernando, Asensus Surgical President and CEO. “We are particularly enthusiastic to see hospitals in the United States leveraging the capabilities of the ISUTM. With features such as precise real-time intraoperative measurements and digital tags, the ISU’s intraoperative intelligence sets Senhance apart from other current and future robotic systems.” Asensus Surgical's technology platform, Senhance Surgical System, is the first of its kind digital laparoscopic platform that leverages augmented intelligence to provide unmatched performance and patient outcomes through machine learning. Senhance goes beyond the typical surgical robotic systems, providing surgical assurance through haptic feedback, eye-tracking camera control, and 3D visualization, and is the first platform to offer 3 mm instruments (the smallest instrument available in the world on a robotic surgical platform). The Senhance Surgical System is powered by the Intelligent Surgical UnitTM (ISU). The ISU enables machine vision-driven control of the camera for a surgeon by responding to commands and recognizing certain objects and locations in the surgical field, and allows a surgeon to change the visualized field of view using the movement of their instruments. “Prior to our adoption of Senhance, we avoided adding a soft tissue robotics platform to our general surgery department because of a lack of meaningful benefits offered to our surgeons and patients by competing platforms. That has changed with Senhance and the platform’s innovative intelligent capabilities and laparoscopic foundation,” said Dr. David Gutierrez, Chief of General Surgery at Franklin Medical Center. “Senhance adds a new dynamic to soft tissue abdominal robotics, one that we believe will improve our surgical outcomes, reduce the burden of recovery placed upon our patients, and allows us to bring the highest quality of care to all those we serve.” About Franklin Medical Center Franklin Medical Center is an acute-care hospital in Winnsboro, Louisiana serving Franklin, Tensas, and Catahoula Parishes in Louisiana. Franklin Medical Center has been a part of Franklin Parish since 1970. The hospital has provided healthcare to this area of Louisiana for over 50 years. About Asensus Surgical, Inc. Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance Surgical System powered by the Intelligent Surgical Unit (ISU) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: www.senhance.com/indications. For more information, visit www.asensus.com. Forward-Looking Statements This press release includes statements relating to the Senhance Surgical System and Franklin Medical Center initiating a program with the Senhance System. These statements and other statements regarding our future plans and goals constitute "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that are often difficult to predict, are beyond our control and which may cause results to differ materially from expectations and include whether the Senhance Surgical System will improve surgical outcomes at Franklin Medical Center and reduce the burden of recovery upon Franklin Medical Center patients. For a discussion of the risks and uncertainties associated with the Company’s business, please review our filings with the Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 11, 2021 and our other filings we make with the SEC. You are cautioned not to place undue reliance on these forward looking statements, which are based on our

expectations as of the date of this press release and speak only as of the origination date of this press release. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. View source version on businesswire.com: https://www.businesswire.com/news/home/20211115005326/en/ INVESTOR CONTACT: Mark Klausner or Mike Vallie, 443-213-0499 [email protected] or MEDIA CONTACT: Kristin Schaeffer, 858-354-8850 CG Life [email protected] Source: Asensus Surgical, Inc.


r/Asensus • • Mar 12 '21

DD Asensus employees demographic

16 Upvotes

From the document 10k published by Asensus:

"As of December 31, 2020, we had 138 employees, including 128 full-time employees, of whom 47 were in the R&D department, 12 were in in Quality and Regulatory Affairs, 28 were in marketing and sales, 23 were in in Corporate Administration, and 18 were in Customer Care. As of December 31, 2020, approximately 33% of the Company’s workforce were female and minorities represented approximately 19% of the Company’s workforce. As of December 31, 2020, approximately 58% of the Company’s employees were located in the United States and 42% were outside of the United States. In 2020, we hired 24 full-time employees."


r/Asensus • • Nov 01 '21

News Asensus Surgical Announces Shinmatsudo Central General Hospital in Japan to Initiate Senhance Robotic Surgical System

Thumbnail ir.asensus.com
20 Upvotes

r/Asensus • • Mar 10 '21

Poll Guidance FY 2021 revenues

13 Upvotes

If they will give a guidance tomorrow, it will be:

146 votes, Mar 12 '21
92 > 10 mln $
54 < 10 mln $

r/Asensus • • Jul 09 '21

News Senhance Surgery Spotlight: Sinai Chicago

5 Upvotes

r/Asensus • • Mar 12 '21

DD Senhance manufacturing...

12 Upvotes

From the document 10-k that Asensus published yesterday:

"The Senhance System is manufactured for us by third party contract manufacturers. We or our manufacturers acquire raw materials and components of the Senhance System from vendors, some of which are sole suppliers. We believe our relationships with our vendors and manufacturing contractors are good. We further believe that we have the manufacturing capacity and inventory reserves to meet our anticipated Senhance System sales for the foreseeable future."